YiChang HEC ChangJiang Pharmaceutical Co Ltd 2021 Sustainability Report
Company: YiChang HEC ChangJiang Pharmaceutical Co Ltd
Sector: Manufacturing
Country: China
Year: 2021
Type: Sustainability Report
Pages: 102
The report describes a 2021 revenue decline to RMB913.79 million while the company continued expanding its product portfolio, including the launch approval of self-developed Insulin Glargine Injection. It reports total greenhouse gas emissions of 63,666.38 Tonnes CO2e and a workforce of 3,616 employees. The report also documents extensive ESG governance, environmental management, safe production, employee development and responsible supply-chain practices.
Data Services
From bulk PDFs to structured indicators and machine-readable documents.